Trial Profile
Interest of the Peak of Reticulocytes in Chronic Hemodialysis Patients Treated by Mircera
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 08 Mar 2022
Price :
$35
*
At a glance
- Drugs Methoxy polyethylene glycol-epoetin beta (Primary)
- Indications Anaemia
- Focus Therapeutic Use
- Acronyms RETICERA
- 03 Mar 2022 Status changed from completed to discontinued.
- 16 Dec 2021 Status changed from active, no longer recruiting to completed.
- 28 Dec 2020 Planned End Date changed from 22 Jun 2020 to 22 Jun 2021.